Veraxa Biotech Holding AG (VRXA) Receivables - Other (2024)
Veraxa Biotech Holding AG (VRXA) posted Receivables - Other of -$118895.2 for Q4 2024.
Veraxa Biotech Holding AG (VRXA) Receivables - Other (2024) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has reported Receivables - Other for 1 consecutive years, with -$118895.2 the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Receivables - Other changed N/A year-over-year to -$118895.2; the trailing twelve-month figure through Dec 2024 stood at -$118895.2 (changed N/A YoY), and the FY2025 full-year result was $1.2 million, up 1107.94% from the prior year.
- Receivables - Other held at -$118895.2 in Q4 2024 per VRXA's latest filing.
- In the past five years, Receivables - Other ranged from a high of -$118895.2 in Q4 2024 to a low of -$118895.2 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -118,895.21 |
| Dec 31, 2024 | -118,895.21 |